Osteoporosis and osseointegration of implants.
According to medical literature, osteoporosis and related bone pathologies are increasing in epidemic proportions. The exact etiology of the disease is unknown, but hormonal, dietary, and genetic factors all contribute to the related loss of bone density. In the disease process, bone loss occurs throughout the body. Research indicates that the mandible and maxilla are affected, and show oral manifestations. There is no scientific data to contraindicate the use of two-step osseointegrated implants in osteoporotic individuals. The purpose of this article is to review the literature regarding osteoporosis and its relationship to oral bone loss.
Baxter
J C
JC
Prosthodontics, Northwestern University, Chicago, IL.
Fattore
L
L
D016301:Alveolar Bone Loss / Q000209:etiology*; D002118:Calcium / Q000627:therapeutic use; D015921:Dental Implants; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008297:Male; D016348:Osseointegration; D010024:Osteoporosis / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D014807:Vitamin D / Q000627:therapeutic use
D015921:Dental Implants; D014807:Vitamin D; D002118:Calcium